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The mk of the endolhclium in mntmlling vwular tone has 
been increasingly mccgtdrcd WTI the pojt decn!x (1.2). Im- 
&rated in patients witi ebcrosdemsk (3) and in condition 
predisposing to the development of athercaclcmsis. such u 
hypercboleaemlrmia, even before rtruchual rm~ubu disc&w 
k eaobisbed (4-9). lldi impaired ctithclium-dqxndcnt YIWI- 
Oxidative modilica%n of low dcnsitv liworotein ILDL) 
may br imponant in the development bf &tosc:er&is in 
hvwcholrstcmlemk admilk and humans WI). Oxidatively 
iidiliud LDL may also impeir the function o~si!&+l traw&- 
tion pathwq that link cndorhelkl cd: surface receptnn to 
stimulation of nitric tide production (11.12). Rcceat interest 
in antioxidant herapy has primarily focused on its antidthero- 
pnic cUccts, whose mechnnirm k believed to be the incurpa 
ration of lipaphilic antioxidant vi!amins into the lipoprotein 
pnticlc. thw pmtcctin~ LDI. fmm the proaxidant environ- 
ment of the arterial wll. Thih clfcct could reduce the forma- 
tion of fn;lm cclk and rctnrd the de\vlopment or prugtcssion 
of alhcmsdcnxis (13). However. protection oi LDL from 
oudaia modification by antioxidant vitamins cmdd ab im- 
pimc cndutbelial production of nitric oxide. Thus !he nim of 
thir study was to dclemine whsrhcr antioxidant vitamins muld 
revwe abnomml cndothdial fun&n in hypaEholcstemlemic 
patients over a period of :bne too brief to be likely to a&t 
atherogmesir 
Methods 
Stug patleo& Hypedmles.kmdemic patients 18 to 75 
yews old with fasting total cb”le&rol levels ~250 lngldl were 
eligible for study. Nineteen asylnptomatic hypaeboleaer- 
okmic palien& 9 men and 10 women. aged S? f 9 years. 
withoat known atbsrosdemtic cardic+a.wular disease, *em 
enrolled Their lipid protIle showed the following valursz mtal 
cbol~mlZ83 + 22 mgldl tigiyceridrr 172 5 79 mgidl, LDL 
I97 5 31 mg(dl and high.density lipoprotein (HDL) 48 + 
13 mg/dl. All ptienlswere irce from bypmtension, diabetes or 
other systemic disease and were not rc&ving medication or 
hormone trplacemml therapy. 1 hree wen cigaretle rsnolers. 
No patient had akcn any dtolcstcrol-loweri”g agents in thz 
pmious 2 months or a”y antioxidaot vitamin suppkmenb in 
the psceding 6 months. All paicntr had normal findings “II 
phyrical exambvdion. rest dectmcardiim (Eco). chest 
X-ray study and symptom-limited treadmill exercise test per- 
fom~ed with the slandnrd Bruce protxol. No patient expmi- 
enced angina peclnris or daudication during exwcirc. Four- 
tern be~llby voluoteer subjects. 6 inen and 8 women. a&cd 
48 ? 8 yew were dso studkd. Their lipid pmRle tied the 
folkwing vulwc: total choksteml I64 2 HI m$dl, tri8ly.xfde 
83 z 31 mgldl. LLL IO2 + 25 mgldl and HDL 50 f I3 m&II. 
Thek: wbjcclr were screened by clinical history, ECG and 
blanl chemistry rtudics I” cosure the abwnee of mrdiwaru- 
far or other syrtcmic disease. and tkcy were rtl nceiving 
medicoliom vitamin suppkmcnk or kormooe rcpkxcmenl 
thcmpy. 
Protocol. ‘III” study will approved by the National Hrart 
Lung. and Ekrd lnslihllc Rwiw Boxd, nod ull p&&iink 
#I@ willen informed conml. Akohol. coffcinc mud smoking 
were prohibited for 24 h before the u&j. A cmmula (1.75 in. 
I4dS cmb 20 gauge. Arms) WI inserted into tkc brachid 
aflrrry of the nondominant mm. A bkwd remplc for lipid 
proliir was obtained. Forearm bkmd flow studies were per- 
formed by using strain gauge pkrhysnmgraphy, as prevkmsly 
described for ou1 Inborntory (14). Erie&. I mercury-Hlkd 
Sitic r:min gauge connmed to a plethymtognph (nhxkl 
EC!4 DE Clokanson). in lwn connected to a chun amrdcr 
(PItarm& LKR Giotechnology. Sweden). was calibrated to 
measure fomamt wlume cbungcs. A mpid cuff inflator (model 
EIO. DE Hoksnson) wus used to occlude venou ou~lluw from 
the extremity and R wrist ~6 was in&x! to M mm fig over 
systolii prixurc I min before lxch mear”a”le”1 to exclude 
the hand circukdiin. Forearm blocd flow was expresxd 6s 
mUmin per IW ml of forearm vulume. Bluchial ortmy prcssurc 
wz mmsored diily fwn the iotmmlerid alhcar (Spw&bs 
mcdel903@& Forearm vasndr reskkmm was cakxlated as the 
mean art&l prnaun dii by the fo,earm Mond Row and k 
cxpxwd as units. 
An intraarterial infusion ofS% dcxlnae solutionwrsbcgun 
at 1 mUmin and cootboned tbmu@“zt drug foG”ns. LtaszJ 
meawemcnLI mm obtained 3 mfn a&r the start of the 
iofusion. Forearm tlocd 6ow was then meawed during 
intmarterid imirsions of acc@chdine chloride (Sigma Chcm- 
bal) at 7515 and 30 &dn. and sodium nilmpmssi& at 0.8. 
Iband3.2 Ilglmin. I&sf”n rat”, (025,0.5 and 1 mUmin)we 
idendcal for each drag Each dose of @ was iufwd for 
S min and forearm McwJ Row was measured in the I~I 2 min 
of each dew. The o&r of admi&“ad”n of these drugs was 
randomized aad a 30-min rest period emued between infu- 
skms. 
Iroll(im of LDI. In 14 hyperchokstemkmic patients and 
8 normal subjects, plasma wo separated by In, speed centrif- 
uylion. To bdtibit suwoxidation. cthylmediambxteuaantic 
add (EMA) (I @ml) and butylated hydm*tolucne (WIT) 
(4.4 pg/ml) were added to the samples ss soon as the plasma 
was separated horn the blood cells. To irdalc LDL tivm 
plasma. by wqucnlial ullmcentribgalion between tides of 
I.006 and lBb3 @tl w pmkwmcd aspreviowly described 
(IS). Before lbc oxidation nsryw Lxgn, iadividual sample5 
of LDL wre didyred in a 4Wf”ld volume of O.OI movlita 
phospbatc bu&r 0.16 m&liter mditto~ chlorkk (N&l) solu. 
lion QBS). pcI 7A with Ill ~obliter EDTA (FW-EDTA) for 
?4 h, wit11 a ckaye of the dialysis mkttio” I&I I2 h LDL 
protein &tcmtinalion was pc&mwd l&on Ike rxbklicn 
assay by osing the BCA method (Fierce) (la). 
LDL oxiwbn -. Dxitliilii of LDL w awncd 
wkg a qxctrc@otomettic tedmiqtie nbnilar to lbat described 
by Ertcrbaur et al (17). LDL sampks rnre diluted to a tied 
protein cmlce”l1&!” of SO &ml i0 1 pmolniter EDT&ws. 
Teen pl da 05 mlnvliter CuClt sdtttion was added to I ml nl 
LDL (Anal concmtmtion 5 ~l/llter mpper chloride 
[CuCl,D, Peroxidation of LDL war agiearcd bq miing ullra. 
viokt spectropb”t”metfk abrmbpttce of234 nm as an i&x of 
mnjugmed dine fom&nt after the ioitkttion ofoxidntion by 
CuQ. Absorba~ was meawed a! Wmi” inkmlr for 
7. min and half-bouriy thenafter for a total of 7 IL llte 
change in d%omaee with mpect to lime w?; diiidcd inlo 
three wo~~ut’kc phaw. as piwioosly described: lag tiote, 
-lion pbasc and dccom~ensation pbasc. I& lag lime 
was d&cd aa the intcrwd bctwcn initiation of oxidation by 
lhe addition ofCuCll (rime 0) and tb intercqn of the tangent 
of the dope of tltc abwrbaore curve duriw the pmpagation 
phase. The propa@on pbsse. in which polyxnsrtontcd fatty 
acids of LDL nre rapidly oxwened into conjugated kydmper- 
oxides, is reprrncntcd by lhc mpid ittcreue in abwbnorc with 
tespcn lo tkc plateau of the lag lime. Ilw drrumpcnsatkm 
pbnsc is 11,~ time period after the point of mnxbnal absortuoce 
and b cbancterlzed by a” initial decrease il: the abmrbaocc 
for approximately 2 h lollowed by a gradual increase in 
dworbmnce, due to dcmmpnsation of lipid hydmpcroxidca 
Aoalytk metkodt. Plnvna cholestcml and triglycerides 
were qoantitated by automated eozyontic teehnkpzes on an 
Abbott Lab”mlories \‘SZ analyzer. HDL cl!&stcml wds 
qoantificd in plasma after dextmn alfate precipihtion. Plasma 
hta-camtcne and vitamin E bxk were measured ty ldgb 
!613 
pwkwm~ liquid chmmato~phy with Rwnmtc~rk Ctcc 
tii (IS). Vitambt C kwk WE measuwd k the raectrwh+ 
ton&manwe afthe 2Adinilra phe&hy&infderi&c 
oFdc)ydnrsscolbieacid(19). 
Vltamla a@emeal slt@y. Afkr pwfonnvla of the br,w 
line LDL tidii.ion assay and forearm flow study. byperch* 
kuc&mic aatients received daily trealment with beta- 
SWkUmlm&k.Ditncmrbenwaatwmwtsot 
cuntbttmus data (qes, lipid kwls, vitamin Icvcls. LDL oxida- 
tion data) wae compared by paired or unpaired Student I test 
a appmpiate. Ihe forearm Smv reqmsa to acetylcboline 
and mdium suroprusside in the two Snaps at bacline and in 
the hypd&&emlemk patients before and after vitamin 
twment were cornpad by am&k d wiatce for repcatcd 
mcstucs using a multiple liar rcgrerrion model that in- 
chukd dummy variable to correct for wriability behwcn 
7.5 15 
Acdylcholine 
Wmin) 
Baseline fes9anw to ace@&line and sodium nitrqos. 
aidt. The fararm vuodilatur qonsc to aeetylcholine was 
significantly lcwa in hypfxcholatemlemic patients tbsn in 
nurmal subjects (p < 01)l) (Fi. IX with a maximrl Lrcafm 
Row of 9.8 + 18 mUmin per IW ml in patients compared to 
15.9 2 8.1 ml/min per IOU ml in nomml subjects (p = lJ.03). 
The relatti deaease in f~renrm vaaculr resis!x~ie with 
ncctylcholine from a baseline of 37.2 * 24.9 U for patients and 
37.9 z 9.1) U fnr normal subjects was much lamer in patients 
t!x in nonaal objects (p < OJII) (Fig. I). Because hqelrhp 
ksterokmk Datients were sliitlv older than normal subkzts 
tl&response to acetylcholine war pm&for normal subjects 
(r = -0.49. D = 0.07) but not fur hvtwcholcsterolemic 
pal’cnts (5.9 + 29 M 13.4 t 9 3 mUmin 100 ml, p = 0.03). 
Stxfium Nllro~s 
OwhW 
whcrcas it was simikr for mak sod fcn~olc normal subjects 
(15.4 i lO.Ovs. 15.5 + Nix), p = 038). The rerpcllls to sodium 
oitropruraidc was the same in both group (9 Z), with a peak 
flow of95 + 4.2 mUmin per 100 ml in patients compared to 
9& 2 2.8 mUmin per IOU ml in normal subjects (p = 0.72). 
Ase2ne meneurpaclll of LDL oxldtibm. The IQ times to 
onset of LDL axtdation wcrc sboilar in pnticnts and normal 
wbjccts(114=4lvs.119+ 16min,p=tl69),asmrctbc 
mrmbnni oxidaiun rates (0.66vr. 0.69abwbimwb. p = 0.16). 
For normal subjects, the lag time to onset of LDL oxidution 
uxrclatcd mar@~ni!y with the pl= triglyceride level (r = 
Ok% D = O.MI but not with totnl cholcatcrot fr = 0.00~. yerv 
low &n&y l&protein (VLDL) (r = O-14), LdL (I = d&j& 
HDL (I = MO) levels. For p;ltimts, lhe log time of LDL 
oxidation corn&cd marginntiy with the plrc& ttiglyc&dc 
levels (r = 0.52, p = U&54) and significantly with the pltruno 
VLDL (r = 0.67, p = O.UlB) and LDL (r = 0.56, p = U.W) 
levels. Tbcrc was no corrcia~hm with tbc total choisstcrol (r = 
MJ7) CT HDL (r = 0.21) levels. Further. tbcrc was no 
correlation bclwcen the Isg time to oflsct of LDL oxidation in 
hypercholentemkmic patients and their plsams &+carotmc 
(r = 0.01). vitamin C (r = 0.40) or vitamin E (r = a38) Icvek 
For both study groups, then WI no correlation bctwcco the 
lag time to onwet of LDL oxidation and the maximal fonarm 
20~ respmmt- o acctylcimUl (r - -0.15 for nmmal wbjccts 
sndr = -Udl for fmtients). 
vllarln IMppkMats L &sRWsW&mk pulala. 
After I :lnmth of treatment with bcta-carotcnc, vitamin C and 
vitamin E qqrlcmcnts. pissma lcvck of all lbre vitamins 
WR in-d owx baseline valus ktn+%okne a21 t OD7 
to 0.34 2 MI nl&n (p < OIKll); vitmnln c IB 2 U.3 to 1.9 f 
0.7 m&U (p < lLOlll); sod vitamin E 2.2 2 0.7 to 35 + 
1.9 m@dl (p = aOi). Tk plema lipid l&s (total rhokslcrol 
2&l f 43 I@, tridywridcr 182 2 114 a@di. LDL 192 2 
41 n@dl, HDL 46 z I2 m@dl) were unchsngcd from baseline 
VllUCs. 
Efsctd*mlnsuppkmsnbwLDLoxtdalkThe 
cuidkability of pIarms LDL *was rcduad after I month of 
vibunio supplement ~hcrapy, with a Ii ‘_ 67% increase in the 
lagtimetoonrtrrdLDLuda~n(p<0aal)anda2 
dccrcasc in the maximal rate of osidation (p c OaOl) mm- 
pared lo basek mcu~yrcmenei (Fig. 3). ‘lhc lag tboc IO omzt 
of LDL oxhktion on vitamin suppbmentr corrclatcd rtmngly 
with the pissrna vitamin E lcvct (r = 0.72. p 3 U.003) but cot 
with the plasnm bctn-~~~cnc (I = at3) or the vitamin C (r = 
0.10) Icvcl. The lag tbnc to on& of LDL oaidmion conelatcd 
signifkaut!y with plasma hislyceridc (C = 0.73, p = aw2). 
VLDL(r=0.66,p=0.009)wlLDL(t=054.p=0&4) 
levels and marginally with fhc total chukstcwl kvcl (r = 0.N. 
p = 0.05) but not with the HDL level (I = 0.15). 
wed of 84ludn supplem~s M ferelum vnscnhu Iv. 
spwes. AI the I-month followlrp forearm Hw sludy during 
vitemin therapy, basal bk-zd flow was lower (22 c 0.7 vx 27 f 
0.6 mVplin per 1M) ml. p C 0.001) and basal forcurm vascular 
m&tmcehigher(45 f 17~~36 2 MU. p < llflll)than in the 
bmdinc swdy. Mcan ancriol blurd prcssorc ws rimilsr for 
bath studies (86 2 9 nt baseline vs. Xx 2 Y mm Hg wi!h 
vimnim. p = fC3). Despite the significirnt r&a of vitamin 
tbemm on oxidhnbilitv of LDL the wrodiiator msmxx to 
acehlijaline mmaind d-d (Fii I). with ihe peak 
forearm blood Rw of 9.6 ? 6.3 mUmin per IOU ml with vilamin 
therapy eenqwed to 9.8 * 7.8 mlimin per lo0 ml ilt baseline 
(p = 0.57). lhe pak r?xcarm Row msponsc 1” acerylcholine 
was similar belween basdinr and vitamin nudicp. for men (KY 
2 29 vs. 6.6 2 3.2 mVmin per IM ml. p = U.43) and wmen 
(124 ? 93 n II.0 + 6.0 mUmin per 100 min. p = Q II). Thx 
vawdilator qxmsc to aodium nhroprumkk was unchanged 
by vitamin arpplementa (Fib 3), with peak Rowi of Y.4 f 
4.7 mvmin per LOI ml with vitamin thempy compared to Y.5 i: 
4.2 mvmin oer IO0 ml 81 baseline I” = 0.61). Them ws no 
mrrelulon bewccn the timr to “n&t of LDl_ oxidutkm nml 
the mnximnl fomnnn Row renporue to acctylcbolinr (I = 0.06). 
The variances for the change in xctylcboli~.stim”bded 
forearm flow were 33.7 for the uwmgc wtylcholinc rcspnnsc 
(7.5, I5 and 30 timin) nod 51.5 for the peuk xclylcholinc 
responr Given the sample size of 19 policnts. ““I study hi* 
lXl% power (alpha = 0.65) to cxhdc with respccl I” biwlioc 
values en werage inerewc +45% sod a peak incmanc ~47% 
in acctyichdine-stimulad forearm flow wilh vitamin ~hcmpy. 
Discussion 
Consistem with previous reports from our labomtory (9) 
and athem (6,s). padems with hypcrcholcrtcrokmia in the 
pmsem study exhlhibilcd ;m impaired forearm Mood Rav m- 
epxw to the endotbeliumdepadent vasodiiator xetylcho- 
line wmpwnl with that of normal subjects, wxreas forearm 
Row repows to the endothelium-independen1 vasodilruor 
sodium nitroprosside were similar in the two group. This 
impilirmenl in acetykb”linwimukwd Row was more pm- 
noowed in nude than in female hypemh&sioi”lendc pmients 
Becmsc “xi&lively modified LDL may inhibit Ihc producdon 
of nitric oxide (11.1’2). we chase to menswe the oxidative 
aowptibility of LDL from hypcmholcwerokmic piem? and 
then assess the hnpact ofnnhoxidanl vimmin supplemenmtion 
on both oxidmive susceptibility of LDL and endothelial vase 
dilamx limction l%e sweptfbility of LDL to oxidation III base- 
lint VCIY Gnilar in our ~o!&emkmic patients and nxmal 
subjccta P linding mat probably r&as tic pmte&e el?eecc of 
vikunim horn dkkey auces tbot become i-d into 
cinzoloting lipopmtehx (17.X-34). Hamver. the heigbteoed m- 
lem:and~of~~rm~kinthewbv~unll”f 
h_yperchol&emkmic patients mi&l rapidly e&msl the FX”IK. 
tiw clfoz of &my antiaidant vimmins incuqxmmxl into LDL 
pad&. We hylx4hesized thrill nmioxiLrd vitandn sopplemenls 
might pwtwt LDL from “xidadon and impmxe end”theli”l 
pwdwdon of nitric “xi&, kadillg to bnpmxd vnaxeloxadnn in 
qmmz to endothrlhtmdqxndent vasodilator agonists 
Vnsmnomr hnetba In hypercholeslendemia. Previous 
xtudicr pcrfomwd in hype~lw&.temlemic patin (4-Y) hove 
shown impaired cndorhcli”mdepen&nt wodilntion and ni- 
tric “xididc biowailabilii. Studies performed on animal sbxial 
time in vitro have provided insights into the mechanisms of 
this ;Ibnonal eedothelial fur&on in hypercholertemkmia 
Mangin et al. (11) showed that oxidalivcly moditid LDL, but 
not natiw LDL, impairs the vamrelnxnnt responx of arterial 
rings to awykholine. Shimokmva ct aI. (I?) showed lhat fbc 
ptinuxiir iwin-sensitive Gi protein-dependent signd transduc- 
tion pathway linked to adcnylyl qzlare (utilized by scetylcho- 
line and other agonists) is imptired in due fmm hypxcho- 
kstrrokmic ~“iaok with early nthemsckrwb Keaney et al. 
(351 recently repwed that vitamin E (oppmtimalely 3.CtXl 
NJ/day) fed to hypercbolestemlemie rabbits for 28 days, in- 
cgoinp plasma levels by >MIoB and aorlic tiwc ICV& by 
ihWd with reopen te motml level+ pmkoged the kg time of 
LDL oxidetion and imprewed ecetylehoiiee-induced rekxetiw 
of aerial rings from these animals. 
isikJddaot vihmios in hvD(rrlo(gl emkmk. Illese oh- 
servatiom provided incootivevior our study iovaigatiog the 
effect of a combination of antiositkot vitaodor previ&ly 
shown to reducz the rweotibiiitv of LDL from humans D 
oxidation WC found that I ~th~ofvitamksoppl~ntotion 
with rektiveiy high dws of betaamtenr vitamin C and 
riromin E kerepsod plasma imk of these deodnr and 
prolonged the Onset of midotica of LDL and decreased the 
maximal rete of LDL oxidation from hwwchoksterolcmic 
potimts reswosw.imikr to those reportddin oomtol sobjti 
&ZE) and gareite smoken (29). ihe pdongdmi diime 
to omet of LDL oxidation in hwerchokawokmk mtknts 
mrreinted strongly with the plasma level of vitamin E’ after 1 
month of edmkistmtion. but eat with plmme kwlr of the 
other vitamios_ sot+zting that the major antioxidant &et of 
the vileodor we administered was probably rendered by vita- 
min E. The stroogcunektiooof the kgtinrof LDLaxidatko 
with ttiglycctidcs and VLDL kwk in hypmhol~lemic 
ptknts. both before and efter vitamin soppkmootatks may 
kdicate the irnpntance of triglyceride in determining pksma 
vihmdn E levels or in the incorpoodioe ofvitmnk E into the 
LDL panicle (30). However, despite the benetkiil e&c& of 
, ..,,. 
okmic oaticoL* in oorstodv. the forearm Row rcsnow to the 
proved after I month of vitamin soppl~entotioo. 
Antioxideot viteminl end vwpo(or reeponekmen 
There ore ~cw.mi potential reasons why we did not see ee 
improwment in en&tltelial rcsponsiveoesu despite oo otttiox- 
idont clkct ofvitemks on plasma LDL First. with our spmvk 
sine of I9 ptknis and th; variance of W&J Row mea&- 
meats in response tn aeetykholinc, oar study rules out o +45% 
inrrear in tlm with vttsmin thaepy over baseline vakes. 
Aceordingty. P iaacr improvement ie~&ylch3lke.rtimuieted 
Row could heve been miswd by ow sJedy. Seamd. the d&a 
in rndoihcliol fun&o in hypemholestemkmk patients may 
be irreveratble. This prosibiliiy k x~newhat oolihly PS receot 
studier have indicated that imoaired endothelimnAwttknt 
wodiklor respolacs in hype~hokrtorokmie poticnt; coo be 
impraved by admkistration of L-arginine. the suhstrnte for 
nitric mide pmductioo by way of nitric oxide syothase in the 
eodothelium (31-33). oilhoogh e rant study (34) did oat 
cootlrm this fiodiog. Further, sevcrol stodiis (35-38) indicate 
that lid redo&n therapy improws cndothclium~dcpendeot 
vasodiiator fonctioo in hvperchokstemkmic oeticota Third. I 
boefickl etkct of v&do roppkmentadon may require 
higher daes of vitamins 01 longer do&on of adodoirtretion 
ta pcmdt LDL with greater antioxidonl viteodn contoot to 
penetrate the wapel well and accomokte in solikiat qoantity 
to affect codotblial nitric oxide orwJoclion or bii&btUitv. 
In this regard, Keaney et al. (zj) showI in hyperchok& 
okmie rabbits weighing -3 kg vwokr benefit of a total dally 
dose of vitamin E elmmt fewfold hiier thnn thef used in our 
*oar. 
Finally. the lack of enhancement of ecetykholioe- 
sb.mdekd forearm blood tlow after aotioxiit vitamin sop 
plementllian in oar study rakes the possibility that ox&d 
LDL is 110( &rely responsibk for depmud endotholkot- 
dependent vaediktke k hypemholesterokmic heoar !3o- 
t.wa&kaoionsaodetherrenetiveoaygearpuks~ced 
withk the vggi well in hypercholatcmkmie (39) may be 
unaEeaed by sntkxident vitamins_ resultkg io persistat 
smooth mo& amstrktioo (40) or degradation of nitric oxide 
to bkk@tally imctivo nitrogen caitk compounds (41) Noo- 
vitamin aotioxidoota m aotiox&ot enzymes or coommitaot 
redoctiooin LDLkvekrybe required tosl~~impnxemenl 
in mdotMiumdepeodeot vosndiktion in &emholeaa- 
ok& peticots. Addltkmdly, more semJtia tedmiques mey 
be teqtdad to she+ lollgunn dtaoges in tixearm vsncvkr 
reBpo* 

